Publisher: Adis International
ISSN: 1174-5886
Source: Drugs in R&D, Vol.4, Iss.1, 2003-01, pp. : 52-54
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
AMI – ‘Acquired Microbe Invasion’?
Heart Drug, Vol. 4, Iss. 2, 2004-05 ,pp. :
Drug therapy after AMI on the rise
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 493, 2005-01 ,pp. :
US costs highest for AMI hospitalisation
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 495, 2006-01 ,pp. :
Cost-effectiveness of sirolimus-eluting stents in AMI `debatable'
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 583, 2009-01 ,pp. :
Angioplasty cost saving versus prehospital thrombolysis for AMI
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 475, 2005-01 ,pp. :